P
Pelage Pharmaceutical
Stimulating hair growth by targeting hair follicle stem cells, activating dormant cells in all forms of alopecia, and delivering a scientifically based, non-invasive, topical small molecule drug…
About Pelage Pharmaceutical
Pelage Pharmaceuticals is a pioneering biotech company focused on developing scientifically based treatments for hair loss. Operating in the pharmaceutical and biotechnology market, Pelage Pharmaceuticals aims to serve both men and women who suffer from the emotional and social impacts of hair loss. The company's core product is a novel drug that targets hair follicle stem cells, a groundbreaking approach based on discoveries from UCLA. Unlike existing therapies that address external factors, Pelage's solution activates the unique metabolism of hair follicle stem cells to stimulate hair growth. The business model revolves around the development, clinical testing, and eventual commercialization of this innovative treatment. Revenue is generated through the sale of the drug, once approved, to healthcare providers and directly to consumers.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Los Angeles, United States
- Employees
- 11
- Open positions
- 1
- Dealroom signal
- 83.6/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Oct 2025 | $120M | $480M | Main Street Advisors · YK Bioventures · Visionary Ventures · GV | ↗ |
| SERIES AOther financing | Aug 2024 | $14M | $84M | GV | ↗ |
Growth signals
Latest recorded traffic for Pelage Pharmaceutical is 70K monthly website visits, up 12.9% over the last three months. Pelage Pharmaceutical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
GV
Visionary Ventures
Main Street Advisors
YK Bioventures
ARCH Venture Partners
Other known investors1 additional known investor
University of California, Los Angeles
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pelage Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pelage Pharmaceutical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.